UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (1), p.261-266

2012

Volltextzugriff (PDF)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice

PloS one, 2016-01, Vol.11 (1), p.e0145920-e0145920

2016

Volltextzugriff (PDF)

Muc1 is protective during kidney ischemia-reperfusion injury

American journal of physiology. Renal physiology, 2015-06, Vol.308 (12), p.F1452-F1462

2015

Volltextzugriff (PDF)

A Tissue Engineered Construct for Laryngeal Regeneration: A Proof‐of‐Concept Device Design Study

The Laryngoscope, 2022-06, Vol.132 (S9), p.S1-S11

2022

Volltextzugriff (PDF)

The neurotrophic potential of human platelet lysate substitution for fetal bovine serum in glial induction culture medium

Neuroscience letters, 2020-06, Vol.730, p.135025-135025, Article 135025

2020

Volltextzugriff (PDF)

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide

Chembiochem : a European journal of chemical biology, 2018-01, Vol.19 (2), p.121-125

2018

Volltextzugriff (PDF)

Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury

American journal of physiology. Renal physiology, 2016-03, Vol.310 (6), p.F569-F579

2016

Volltextzugriff (PDF)

Downregulation of Hematopoietic MUC1 during Experimental Colitis Increases Tumor-Promoting Myeloid-Derived Suppressor Cells

Clinical cancer research, 2013-09, Vol.19 (18), p.5039-5052

2013

Volltextzugriff (PDF)

The MUC1 Cytoplasmic Tail and Tandem Repeat Domains Contribute to Mammary Oncogenesis in FVB Mice

Breast cancer : basic and clinical research, 2008-01, Vol.1, p.57-63

2008

Volltextzugriff (PDF)

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer

Journal of immunotherapy (1997), 2003-01, Vol.26 (1), p.47

2003

Volltextzugriff (PDF)

Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively Transferred

The Journal of immunology (1950), 2000-09, Vol.165 (6), p.3451-3460

2000

Volltextzugriff (PDF)

Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas

Vaccine, 2007-09, Vol.25 (39), p.6965-6974

2007

Volltextzugriff (PDF)

MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment

Glycoconjugate journal, 2001-11, Vol.18 (11-12), p.931-942

2001

Volltextzugriff (PDF)

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

American journal of physiology: Gastrointestinal and liver physiology, 2003-05, Vol.284 (5), p.G853-G862

2003

Volltextzugriff (PDF)

Dendritic Cell–Tumor Cell Fusion and Staphylococcal Enterotoxin B Treatment in a Pancreatic Tumor Model

The Journal of surgical research, 2002-10, Vol.107 (2), p.196-202

2002

Volltextzugriff (PDF)

The MUC1 Cytoplasmic Tail and Tandem Repeat Domains Contribute to Mammary Oncogenesis in FVB Mice

Breast cancer : basic and clinical research, 2008-01, Vol.2008 (1), p.BCBCR.S655

2008

Volltextzugriff (PDF)

Muc1 Modulates the Beta‐Catenin Protective Pathway During Ischemia‐Reperfusion Injury

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Volltextzugriff (PDF)

Muc1 enhances the [Beta]-catenin protective pathway during ischemia-reperfusion injury

American journal of physiology. Renal physiology, 2016-03, Vol.310 (6), p.F569

2016

Volltextzugriff (PDF)

Down regulation of hematopoietic MUC1 during experimental colitis increases tumor promoting myeloid-derived suppressor cells

Clinical cancer research, 2013-07, Vol.19 (18)

2013

Volltextzugriff (PDF)

Abstract 2403: Glycosylated (Tn) and Anchor-Modified MUC1 Peptide Vaccines Induce Effective Anti tumor Immunity and Break Tolerance in MUC1 Transgenic Mice

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2403-2403

2010

Volltextzugriff (PDF)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice: e0145920

PloS one, 2016-01, Vol.11 (1)

2016

Volltextzugriff (PDF)

Mucin mRNA expression in normal and vasomotor inferior turbinates

American journal of rhinology, 1997-07, Vol.11 (4), p.293-302

1997

Volltextzugriff (PDF)

Characterization of the MUC1.Tg/MIN7 transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas

Vaccine, 2007, Vol.25 (39-40), p.6965-6974

2007

Volltextzugriff (PDF)

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

American journal of physiology: Gastrointestinal and liver physiology, 2003-05, Vol.47 (5), p.G853-G862

2003

Volltextzugriff (PDF)

PERCEPTIONS OF COMMUNITY RESILIENCE AFTER NATURAL DISASTER IN A RURAL AUSTRALIAN TOWN

Journal of community psychology, 2016-04, Vol.44 (3), p.277-292

2016

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)
Bücher
(1)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Animals
(18)
Humans
(16)
Biological And Medical Sciences
(12)
Mice
(12)
Medical Sciences
(10)
Female
(9)
Male
(9)
Mice, Inbred C57bl
(8)
Mucin-1 - Immunology
(8)
Pharmacology. Drug Treatments
(8)
Chemistry, Medicinal
(6)
Immunology
(6)
Mice, Transgenic
(6)
Pharmacology & Pharmacy
(6)
Physical Sciences
(6)
T-Lymphocytes, Cytotoxic - Immunology
(6)
Adult
(5)
Cancer Vaccines - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice

Muc1 is protective during kidney ischemia-reperfusion injury

A Tissue Engineered Construct for Laryngeal Regeneration: A Proof‐of‐Concept Device Design Study

The neurotrophic potential of human platelet lysate substitution for fetal bovine serum in glial induction culture medium

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide

Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury

Downregulation of Hematopoietic MUC1 during Experimental Colitis Increases Tumor-Promoting Myeloid-Derived Suppressor Cells

The MUC1 Cytoplasmic Tail and Tandem Repeat Domains Contribute to Mammary Oncogenesis in FVB Mice

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer

Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively Transferred

Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas

MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

Dendritic Cell–Tumor Cell Fusion and Staphylococcal Enterotoxin B Treatment in a Pancreatic Tumor Model

The MUC1 Cytoplasmic Tail and Tandem Repeat Domains Contribute to Mammary Oncogenesis in FVB Mice

Muc1 Modulates the Beta‐Catenin Protective Pathway During Ischemia‐Reperfusion Injury

Muc1 enhances the [Beta]-catenin protective pathway during ischemia-reperfusion injury

Down regulation of hematopoietic MUC1 during experimental colitis increases tumor promoting myeloid-derived suppressor cells

Abstract 2403: Glycosylated (Tn) and Anchor-Modified MUC1 Peptide Vaccines Induce Effective Anti tumor Immunity and Break Tolerance in MUC1 Transgenic Mice

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice: e0145920

Mucin mRNA expression in normal and vasomotor inferior turbinates

Characterization of the MUC1.Tg/MIN7 transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas

Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice

PERCEPTIONS OF COMMUNITY RESILIENCE AFTER NATURAL DISASTER IN A RURAL AUSTRALIAN TOWN

Suchergebnisse filtern